Institute for Cancer Research

DDMS Program Special Projects

Funding Opportunity Number

PCCR-DDMS-FY2024-01

Funding Opportunity Title

DDMS PROGRAM SPECIAL PROJECTS

Key Dates

Events Cycle 1
Announcement

January 22, 2024
Due

Proposal is accepted through April 15, 2024 on rolling basis until all funds are expended.
Award Amount

up to $30,000

Administrative Contact

Kimberly E Sagendorf (ksagendorf@purdue.edu) 

Funding Opportunity Description

The Drug Delivery and Molecular Sensing (DDMS) Program of the Purdue Institute for Cancer Research (PICR) would like to allocate funds to support the following project options:

DDMS Collaborative Pilot Grant (up to $30,000 per year; may be renewed for the second year upon successful completion of milestones in the form of new publications and/or grant submissions)

Preference is given to projects that (i) align with DDMS’s strategic direction (artificial intelligence/machine learning-based drug delivery or novel imaging technologies (development or cancer application); delivery of immunotherapeutics or nucleic acid agents) and (ii) involve intraprogrammatic collaborations among DDMS members. It is anticipated that the grants will generate extramural grants or publications within a year.

CLICK HERE to submit your electronic application. Once here you can enter your Purdue credentials. 

Qualifications/Restrictions

Applicants must be current members of the Purdue University Center for Cancer Research's Drug Delivery and Molecular Sensing (DDMS) program. Applicants are encouraged to contact program leaders (Yoon Yeo, yyeo@purdue.edu; Fang Huang, huang892@purdue.edu) prior to submission to confirm the availability of fund.

Cost share

This announcement does not require cost sharing.

Funds Available and Anticipated Number of Awards

The number of awards is contingent upon PCCR endowments, gifts and other funds and the submission of meritorious applications.

Award Budget

The proposal will be funded at a level appropriate for the proposed work. The award can be used to support trainees, supplies for projects, and usage of PICR shared resources. See Restrictions.

Award Project Period

See the individual descriptions that follow; however, it is expected that work will commence within less than two (2) months of the date of award.  A project period of no more than twelve (12) months will be assigned to projects. If funds are not spent in 12 months, funds will be returned to the PICR.

Award Restrictions

The budget cannot be used for PI salary support, clerical staff support, travel or equipment.

Award Requirements

Acceptance of an award will indicate your willingness to serve on the Center’s Pilot Grants Review Committee and to possibly represent the Center at the annual Indiana Elks Convention. The awardee MUST acknowledge the PCCR. Suggested publication acknowledgement:

“The authors gratefully acknowledge the <insert shared resource name> and support from the Purdue University Center for Cancer Research, P30CA023168”

No Cost Extension (NCE)

No cost extensions are highly discouraged.  An exception might be considered on a case-by-case basis. Requests must be made to the administration of the PCCR and DDMS leadership.  The center is very interested in making sure the project is advancing and achieving funding and scholarly production for its NCI renewal.

Regulatory

Please note the award is contingent upon obtaining all the necessary regulatory approvals (e.g., IRB, IACUC, PACUC) or a Memorandum of Understanding (MOU) pertaining to the work that has pending approvals.

Reporting

Responding to periodic requests for progress is required.  Triage of future applications may occur if reporting requests are ignored.

Proposal Guidelines

  1. The proposal should be single-spaced and written in Arial font (11pt) with no less than 0.5-inch margins.
  2. Required Proposal Structure:
    1. One (1) specific-aims page which should contain a brief statement on how the project meets the preference criteria of the DDMS Collaborative Pilot Grant (project area; intraprogrammatic collaboration; timeline/likelihood of external grants/publication).
    2. Up to two (2)-page proposal
      1. Proposal Title
      2. Background
      3. Significance
      4. Preliminary data (optional)
      5. Research strategy
      6. Brief description of how the project will be expanded to external grants, publications, or new drug delivery & imaging technologies.
    3. One (1) budget justification
    4. Bibliography
    5. Letters of support from directors of core facilities or external collaborators, as appropriate
    6. NIH Biosketch of investigators
    7. Current and Pending Funding of investigators 

Announcement History and Updates

Funding Opportunity Number Summary of Change
PCCR-DDMS-FY2022-01 Initiation of Announcement